ABBV vs LLY
ABBV and LLY side by side — valuation & fundamentals (public data).
Key statistics
| Metric | ABBVAbbVie Inc. | LLYELI LILLY AND COMPANY |
|---|---|---|
| Market cap | $431.48B | $1.11T |
| P/E (TTM) | 69.0 | 39.5 |
| P/B | — | 32.70 |
| P/S | 7.0x | 17.0x |
| Dividend yield | 2.70% | 0.49% |
| Revenue | $61.16B(TTM) | $79.67B(TTM) |
| Revenue growth (YoY) | 8.6% | 44.7% |
| Net income | $6.31B(TTM) | $26.71B(TTM) |
| Earnings growth (YoY) | -1.2% | 94.9% |
| EPS, diluted | $3.54(TTM) | $29.79(TTM) |
| EBIT margin | 24.6% | 40.2% |
| ROE | — | 60.9% |
| ROIC | 18.6% | 26.3% |
| 1y total return | +25.9% | +84.5% |
Figures from SEC filings · for reference only · not investment advice
Growth of $10,000: ABBV vs LLY
| Metric | ABBV | LLY |
|---|---|---|
| End value | $62.6K | $186.4K |
| Total return | +526.0% | +1763.7% |
| CAGR | +19.4% | +32.7% |
| Volatility | 25.8% | 30.0% |
| Sharpe | 0.67 | 0.96 |
| Sortino | 0.93 | 1.50 |
| Max drawdown | -45.1% | -34.5% |
Based on 2600 common trading days, 2016-04-06 → 2026-08-07 · risk-free 3.9% (current short-Treasury, held constant)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)